家禽疫苗市場－全球產業規模、佔有率、趨勢、機會和預測：按應用、產品、疾病類型、地區和競爭格局分類，2021-2031年

全球家禽疫苗市場預計將經歷顯著成長，從 2025 年的 21.3 億美元成長到 2031 年的 31.8 億美元，複合年成長率為 6.91%。

這項擴張主要受以下因素驅動：全球對價格合理的動物性蛋白質需求不斷成長；確保食品供應免受禽流感染疾病等通用病毒爆發的威脅；以及由於抗菌素抗藥性監管日益嚴格，該行業正從依賴抗生素轉向採取預防措施。全球禽肉和禽蛋消費量的成長需要更高的飼養密度和更最佳化的畜群管理，這反過來又增加了疾病傳播的風險。全面的免疫方案對於維持生產力和食品安全至關重要，這一趨勢在預計到2025年全球雞肉產量將成長2%並達到創紀錄的1.053億噸的預測中得到了印證。同時，家禽感染疾病的蔓延也促使人們需要實施先進的疫苗接種策略。例如，法國已為2024年至2025年間的鴨群採購了6,700萬劑疫苗，凸顯了疫苗接種在維持國際貿易和最大限度減少經濟損失方面發揮的關鍵作用。儘管存在這些有利因素，但維持對溫度敏感的生技藥品至關重要的低溫運輸基礎設施所需的物流複雜性和高成本仍然是一大障礙。發展中地區不可靠的冷藏設施往往會影響疫苗效力，並阻礙小規模農戶取得疫苗。

市場促進因素

全球禽肉和禽蛋消費量的激增是市場擴張的主要驅動力，因此，提高養殖密度和最佳化畜群管理對於實現生產目標至關重要。隨著生產者擴大生產以滿足此營養需求，疾病傳播的風險也隨之增加，因此，全面的疫苗接種方案對於維持生產力和食品安全至關重要。這種規模的擴大也反映在產量預測上。根據美國農業部海外農業局預測，到2025年，全球禽肉產量預計將增加2%，達到創紀錄的1.053億噸。產量的成長與對預防性生技藥品日益成長的需求直接相關，這些製劑用於保護不斷擴大的商業資產，並最大限度地減少高通用感染疾病的日益蔓延感染疾病該行業實施先進的疫苗接種策略。高致病性禽流感（HPAI）等病原體的爆發已造成嚴重的經濟損失和貿易中斷，促使各國政府和一體化生產商優先考慮疫苗接種，而不是被動的撲殺措施。例如，據法國農業和食品主權部稱，該國已採購6,700萬劑疫苗，用於2024-2025年度商業鴨群的免疫接種。此外，國際貿易高度依賴無疫病證明書，而這又依賴健全的衛生防疫計畫。根據美國農業部海外農業局預測，明年全球雞肉出口量將達到1,380萬噸，凸顯了疫苗接種在維持家禽產品跨國流通方面發揮的關鍵作用。

市場挑戰

維護低溫運輸基礎設施的物流複雜性和高成本是全球家禽疫苗市場的嚴峻挑戰。大多數禽類疫苗都是對溫度敏感的生物製藥，遇熱會迅速劣化，因此從生產到農場使用都需要不間斷的冷藏保管。在許多家禽業蓬勃開發中國家，由於缺乏可靠的電力供應和專用儲存設施，疫苗的穩定性常常受到影響。這種物流上的脆弱性削弱了養殖戶對疫苗接種計畫的信心，因為劣化的疫苗無法保護牲畜，導致資源浪費和持續易感疾病。因此，在這些高潛力地區，市場擴張受到阻礙，因為對於小規模企業而言，維護必要的經銷網路成本高且技術難度高。這種基礎設施瓶頸造成了疫苗需求不斷成長與行業有效產品供應能力之間的巨大差距。根據聯合國糧食及農業組織（糧農組織）的預測，到2025年，全球雞肉產量預計將超過1.52億噸。這代表著一個龐大的目標人口，然而，供應鏈的缺陷意味著疫苗供應商仍面臨一些進入難題。如果沒有健全的低溫運輸來確保產品在不斷擴大的生產基地中的有效性，製造商將無法充分利用全球需求，即使感染疾病威脅日益加劇，市場收入成長也將停滯不前。

市場趨勢

疫苗穩定性方面的創新，特別是耐熱和冷凍乾燥製劑的出現，正在改變市場格局，有效降低了與溫度敏感型生物製藥相關的物流風險。製造商正積極擴大基礎設施，以生產這些先進的聚合物製劑，確保即使在低溫運輸不穩定的地區，產品也能保持效能。這種向提高穩定性方向的策略轉變，體現在支持複雜生技藥品生產的大規模工業投資。據默克動物保健公司稱，該公司已投資8.95億美元用於升級其生產設施，重點擴大灌裝機和冷凍乾燥機的產能，以支持聚合物疫苗和生技藥品的生產。同時，市場對多價疫苗的需求激增，使得生產商能夠用單劑疫苗為家禽群接種疫苗，以抵禦新城疫和甘保羅症等多種並存的威脅。這種轉變的驅動力在於營運需求，即在最大限度地提高家禽群疫苗接種效率的同時，最大限度地減少家禽壓力並降低人事費用。這種向綜合疾病管理解決方案發展的趨勢所帶來的商業性影響，已清楚地體現在行業領導者的財務表現中。據菲布羅動物保健公司（Phibro Animal Health）稱，其疫苗部門的淨銷售額成長了12%，而這一成長主要歸功於拉丁美洲和其他國際地區對家禽產品需求的不斷成長。

目錄

第1章概述

第2章：調查方法

第3章執行摘要

第4章：客戶心聲

第5章：全球家禽疫苗市場展望

• 市場規模及預測
  • 按金額
• 市佔率及預測
  • 依應用領域（肉雞、蛋雞、種雞）
  • 產品類別（減毒活病毒疫苗、不活化疫苗、次單位疫苗、DNA疫苗、重組疫苗）
  • 疾病類型（傳染性支氣管炎、傳染性咽喉炎、傳染性喉氣管炎、產蛋量減少症候群、腺病毒感染、鴨子病毒性腸炎、包涵體肝炎、沙門氏菌感染、其他）
  • 按地區
  • 按公司（2025 年）
• 市場地圖

第6章：北美家禽疫苗市場展望

• 市場規模及預測
• 市佔率及預測
• 北美洲：國別分析
  • 美國
  • 加拿大
  • 墨西哥

第7章：歐洲家禽疫苗市場展望

• 市場規模及預測
• 市佔率及預測
• 歐洲：國別分析
  • 德國
  • 法國
  • 英國
  • 義大利
  • 西班牙

第8章：亞太地區家禽疫苗市場展望

• 市場規模及預測
• 市佔率及預測
• 亞太地區：國別分析
  • 中國
  • 印度
  • 日本
  • 韓國
  • 澳洲

第9章：中東和非洲家禽疫苗市場展望

• 市場規模及預測
• 市佔率及預測
• 中東與非洲：國別分析
  • 沙烏地阿拉伯
  • 阿拉伯聯合大公國
  • 南非

第10章：南美洲家禽疫苗市場展望

• 市場規模及預測
• 市佔率及預測
• 南美洲：國別分析
  • 巴西
  • 哥倫比亞
  • 阿根廷

第11章 市場動態

• 促進因素
• 任務

第12章 市場趨勢與發展

• 併購
• 產品發布
• 近期趨勢

第13章：全球家禽疫苗市場：SWOT分析

第14章：波特五力分析

• 產業競爭
• 新進入者的潛力
• 供應商的議價能力
• 顧客權力
• 替代品的威脅

第15章 競爭格局

• Boehringer Ingelheim GmbH
• Zoetis Inc
• Elanco LLC
• Intervet Inc
• Hester Biosciences Ltd
• Vaxxinova GmbH
• Venky's India Ltd
• Laboratorios Calier SA
• KM Biologics Co Ltd
• Phibro Animal Health Corporation

第16章 策略建議

第17章：關於研究公司及免責聲明

The Global Poultry Vaccines Market is poised for substantial growth, projected to increase from USD 2.13 billion in 2025 to USD 3.18 billion by 2031 at a 6.91% CAGR. This expansion is primarily driven by the escalating global demand for affordable animal protein and the critical imperative to secure food supplies against outbreaks of zoonotic viruses, such as Avian Influenza, alongside an industry pivot from antibiotic reliance towards preventative prophylaxis due to stricter antimicrobial resistance regulations. The intensified global consumption of poultry meat and eggs necessitates higher stocking densities and optimized flock management, amplifying the risk of disease transmission and making comprehensive immunization protocols essential for maintaining productivity and food security, a trend highlighted by the forecast 2 percent rise in global chicken meat production to a record 105.3 million tons in 2025. Simultaneously, the increasing prevalence of infectious poultry diseases compels the adoption of advanced vaccination strategies; for example, France procured 67 million vaccine doses for its duck flocks in 2024-2025, underscoring the vital role of vaccination in sustaining international trade and minimizing economic losses. Despite these drivers, a significant impediment is the logistical complexity and high cost of maintaining the cold chain infrastructure essential for temperature-sensitive biologics, as unreliable refrigeration in developing regions often compromises vaccine efficacy and hinders accessibility for small-scale farmers.

Market Driver

The surge in global consumption of poultry meat and eggs serves as a primary engine for market expansion, necessitating higher stocking densities and optimized flock management to meet output targets. As producers intensify operations to satisfy this nutritional demand, the risk of disease transmission increases, making comprehensive immunization protocols essential for maintaining productivity and food security. This scaling of operations is evident in production forecasts; according to the USDA Foreign Agricultural Service, global chicken meat production is forecast to rise 2 percent to a record 105.3 million tons in 2025. This volume growth directly correlates with an increased requirement for prophylactic biologicals to safeguard these expanding commercial assets and minimize mortality rates in high-density farming environments. Simultaneously, the escalating prevalence of infectious and zoonotic poultry diseases is compelling the industry to adopt advanced vaccination strategies. Outbreaks of pathogens such as Highly Pathogenic Avian Influenza (HPAI) cause severe economic losses and trade disruptions, prompting governments and integrators to prioritize preventative inoculation over reactive culling measures. For instance, according to the French Ministry of Agriculture and Food Sovereignty, the state procured 67 million doses of vaccines to immunize commercial duck flocks for the 2024-2025 season. Furthermore, international trade relies heavily on disease-free certifications enabled by robust health programs; according to the USDA Foreign Agricultural Service, global chicken meat exports were projected to reach 13.8 million tons for the upcoming year, underscoring the vital role of vaccination in sustaining the cross-border flow of poultry products.

Market Challenge

The logistical complexity and high cost of maintaining cold chain infrastructure constitute a severe impediment to the Global Poultry Vaccines Market. Most avian vaccines are temperature-sensitive biologics that rapidly degrade if exposed to heat, necessitating uninterrupted refrigeration from the point of manufacturing to farm-level administration. In many developing nations where the poultry sector is expanding, the lack of reliable electricity and specialized storage equipment frequently compromises vaccine stability. This logistical fragility erodes farmer confidence in immunization programs, as spoiled vaccines fail to protect flocks, leading to wasted expenditure and continued disease susceptibility. Consequently, market expansion is stifled in these high-potential regions because the necessary distribution network is often too costly or technically difficult to sustain for small-scale operators. This infrastructural bottleneck creates a significant disconnect between the growing volume of livestock requiring immunization and the industry's ability to deliver effective products. According to the Food and Agriculture Organization, global poultry meat production was projected to exceed 152 million metric tons in 2025, representing a massive target population that remains partially inaccessible to vaccine suppliers due to these supply chain deficits. Without a robust cold chain to ensure product efficacy across this expanding production base, manufacturers cannot fully capitalize on the global demand, effectively capping market revenue growth despite the intensifying prevalence of infectious threats.

Market Trends

Innovations in vaccine stability, particularly the emergence of thermostable and freeze-dried formulations, are transforming the market by mitigating the logistical risks associated with temperature-sensitive biologics. Manufacturers are aggressively expanding infrastructure to produce these advanced large-molecule formulations, which ensure product potency in regions with unreliable cold chains. This strategic pivot towards enhanced stability is exemplified by significant industrial investments to support complex biologic production; according to Merck Animal Health, the company committed $895 million to upgrade its manufacturing facilities, specifically focusing on expanding filling and freeze dryer capacity to support the production of large molecule vaccines and biologics. Simultaneously, there is a surge in demand for multivalent combination vaccines, which allow producers to immunize flocks against concurrent threats like Newcastle and Gumboro diseases in a single administration. This shift is driven by the operational imperative to minimize bird handling stress and reduce labor costs while maximizing flock coverage efficiency. The commercial impact of this preference for comprehensive disease management solutions is evident in the financial performance of key industry players; according to Phibro Animal Health, the vaccine segment recorded a 12% increase in net sales, a growth trajectory attributed primarily to the rising adoption of poultry products in Latin America and other international regions.

Key Market Players

• Boehringer Ingelheim GmbH
• Zoetis Inc
• Elanco LLC
• Intervet Inc
• Hester Biosciences Ltd
• Vaxxinova GmbH
• Venky's India Ltd
• Laboratorios Calier SA
• KM Biologics Co Ltd
• Phibro Animal Health Corporation

Report Scope

In this report, the Global Poultry Vaccines Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Poultry Vaccines Market, By Application

• Broiler
• Layer
• Breeder

Poultry Vaccines Market, By Product

• Attenuated Live Vaccines
• Inactivated Vaccines
• Subunit Vaccines
• DNA Vaccines
• Recombinant Vaccines

Poultry Vaccines Market, By Disease Type

• Infectious Bronchitis
• Infectious Bursal Diseases
• Infectious Laryngotracheitis
• Egg Drop Syndrome
• Adenovirus
• Duck Viral Enteritis
• Inclusion Body Hepatitis
• Salmonella
• Others

Poultry Vaccines Market, By Region

• North America
  • United States
  • Canada
  • Mexico
• Europe
  • France
  • United Kingdom
  • Italy
  • Germany
  • Spain
• Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
• South America
  • Brazil
  • Argentina
  • Colombia
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Poultry Vaccines Market.

Available Customizations:

Global Poultry Vaccines Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

• 1.1. Market Definition
• 1.2. Scope of the Market
  • 1.2.1. Markets Covered
  • 1.2.2. Years Considered for Study
  • 1.2.3. Key Market Segmentations

2. Research Methodology

• 2.1. Objective of the Study
• 2.2. Baseline Methodology
• 2.3. Key Industry Partners
• 2.4. Major Association and Secondary Sources
• 2.5. Forecasting Methodology
• 2.6. Data Triangulation & Validation
• 2.7. Assumptions and Limitations

3. Executive Summary

• 3.1. Overview of the Market
• 3.2. Overview of Key Market Segmentations
• 3.3. Overview of Key Market Players
• 3.4. Overview of Key Regions/Countries
• 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Poultry Vaccines Market Outlook

• 5.1. Market Size & Forecast
  • 5.1.1. By Value
• 5.2. Market Share & Forecast
  • 5.2.1. By Application (Broiler, Layer, Breeder)
  • 5.2.2. By Product (Attenuated Live Vaccines, Inactivated Vaccines, Subunit Vaccines, DNA Vaccines, Recombinant Vaccines)
  • 5.2.3. By Disease Type (Infectious Bronchitis, Infectious Bursal Diseases, Infectious Laryngotracheitis, Egg Drop Syndrome, Adenovirus, Duck Viral Enteritis, Inclusion Body Hepatitis, Salmonella, Others)
  • 5.2.4. By Region
  • 5.2.5. By Company (2025)
• 5.3. Market Map

6. North America Poultry Vaccines Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value
• 6.2. Market Share & Forecast
  • 6.2.1. By Application
  • 6.2.2. By Product
  • 6.2.3. By Disease Type
  • 6.2.4. By Country
• 6.3. North America: Country Analysis
  • 6.3.1. United States Poultry Vaccines Market Outlook
    • 6.3.1.1. Market Size & Forecast
      • 6.3.1.1.1. By Value
    • 6.3.1.2. Market Share & Forecast
      • 6.3.1.2.1. By Application
      • 6.3.1.2.2. By Product
      • 6.3.1.2.3. By Disease Type
  • 6.3.2. Canada Poultry Vaccines Market Outlook
    • 6.3.2.1. Market Size & Forecast
      • 6.3.2.1.1. By Value
    • 6.3.2.2. Market Share & Forecast
      • 6.3.2.2.1. By Application
      • 6.3.2.2.2. By Product
      • 6.3.2.2.3. By Disease Type
  • 6.3.3. Mexico Poultry Vaccines Market Outlook
    • 6.3.3.1. Market Size & Forecast
      • 6.3.3.1.1. By Value
    • 6.3.3.2. Market Share & Forecast
      • 6.3.3.2.1. By Application
      • 6.3.3.2.2. By Product
      • 6.3.3.2.3. By Disease Type

7. Europe Poultry Vaccines Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value
• 7.2. Market Share & Forecast
  • 7.2.1. By Application
  • 7.2.2. By Product
  • 7.2.3. By Disease Type
  • 7.2.4. By Country
• 7.3. Europe: Country Analysis
  • 7.3.1. Germany Poultry Vaccines Market Outlook
    • 7.3.1.1. Market Size & Forecast
      • 7.3.1.1.1. By Value
    • 7.3.1.2. Market Share & Forecast
      • 7.3.1.2.1. By Application
      • 7.3.1.2.2. By Product
      • 7.3.1.2.3. By Disease Type
  • 7.3.2. France Poultry Vaccines Market Outlook
    • 7.3.2.1. Market Size & Forecast
      • 7.3.2.1.1. By Value
    • 7.3.2.2. Market Share & Forecast
      • 7.3.2.2.1. By Application
      • 7.3.2.2.2. By Product
      • 7.3.2.2.3. By Disease Type
  • 7.3.3. United Kingdom Poultry Vaccines Market Outlook
    • 7.3.3.1. Market Size & Forecast
      • 7.3.3.1.1. By Value
    • 7.3.3.2. Market Share & Forecast
      • 7.3.3.2.1. By Application
      • 7.3.3.2.2. By Product
      • 7.3.3.2.3. By Disease Type
  • 7.3.4. Italy Poultry Vaccines Market Outlook
    • 7.3.4.1. Market Size & Forecast
      • 7.3.4.1.1. By Value
    • 7.3.4.2. Market Share & Forecast
      • 7.3.4.2.1. By Application
      • 7.3.4.2.2. By Product
      • 7.3.4.2.3. By Disease Type
  • 7.3.5. Spain Poultry Vaccines Market Outlook
    • 7.3.5.1. Market Size & Forecast
      • 7.3.5.1.1. By Value
    • 7.3.5.2. Market Share & Forecast
      • 7.3.5.2.1. By Application
      • 7.3.5.2.2. By Product
      • 7.3.5.2.3. By Disease Type

8. Asia Pacific Poultry Vaccines Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value
• 8.2. Market Share & Forecast
  • 8.2.1. By Application
  • 8.2.2. By Product
  • 8.2.3. By Disease Type
  • 8.2.4. By Country
• 8.3. Asia Pacific: Country Analysis
  • 8.3.1. China Poultry Vaccines Market Outlook
    • 8.3.1.1. Market Size & Forecast
      • 8.3.1.1.1. By Value
    • 8.3.1.2. Market Share & Forecast
      • 8.3.1.2.1. By Application
      • 8.3.1.2.2. By Product
      • 8.3.1.2.3. By Disease Type
  • 8.3.2. India Poultry Vaccines Market Outlook
    • 8.3.2.1. Market Size & Forecast
      • 8.3.2.1.1. By Value
    • 8.3.2.2. Market Share & Forecast
      • 8.3.2.2.1. By Application
      • 8.3.2.2.2. By Product
      • 8.3.2.2.3. By Disease Type
  • 8.3.3. Japan Poultry Vaccines Market Outlook
    • 8.3.3.1. Market Size & Forecast
      • 8.3.3.1.1. By Value
    • 8.3.3.2. Market Share & Forecast
      • 8.3.3.2.1. By Application
      • 8.3.3.2.2. By Product
      • 8.3.3.2.3. By Disease Type
  • 8.3.4. South Korea Poultry Vaccines Market Outlook
    • 8.3.4.1. Market Size & Forecast
      • 8.3.4.1.1. By Value
    • 8.3.4.2. Market Share & Forecast
      • 8.3.4.2.1. By Application
      • 8.3.4.2.2. By Product
      • 8.3.4.2.3. By Disease Type
  • 8.3.5. Australia Poultry Vaccines Market Outlook
    • 8.3.5.1. Market Size & Forecast
      • 8.3.5.1.1. By Value
    • 8.3.5.2. Market Share & Forecast
      • 8.3.5.2.1. By Application
      • 8.3.5.2.2. By Product
      • 8.3.5.2.3. By Disease Type

9. Middle East & Africa Poultry Vaccines Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value
• 9.2. Market Share & Forecast
  • 9.2.1. By Application
  • 9.2.2. By Product
  • 9.2.3. By Disease Type
  • 9.2.4. By Country
• 9.3. Middle East & Africa: Country Analysis
  • 9.3.1. Saudi Arabia Poultry Vaccines Market Outlook
    • 9.3.1.1. Market Size & Forecast
      • 9.3.1.1.1. By Value
    • 9.3.1.2. Market Share & Forecast
      • 9.3.1.2.1. By Application
      • 9.3.1.2.2. By Product
      • 9.3.1.2.3. By Disease Type
  • 9.3.2. UAE Poultry Vaccines Market Outlook
    • 9.3.2.1. Market Size & Forecast
      • 9.3.2.1.1. By Value
    • 9.3.2.2. Market Share & Forecast
      • 9.3.2.2.1. By Application
      • 9.3.2.2.2. By Product
      • 9.3.2.2.3. By Disease Type
  • 9.3.3. South Africa Poultry Vaccines Market Outlook
    • 9.3.3.1. Market Size & Forecast
      • 9.3.3.1.1. By Value
    • 9.3.3.2. Market Share & Forecast
      • 9.3.3.2.1. By Application
      • 9.3.3.2.2. By Product
      • 9.3.3.2.3. By Disease Type

10. South America Poultry Vaccines Market Outlook

• 10.1. Market Size & Forecast
  • 10.1.1. By Value
• 10.2. Market Share & Forecast
  • 10.2.1. By Application
  • 10.2.2. By Product
  • 10.2.3. By Disease Type
  • 10.2.4. By Country
• 10.3. South America: Country Analysis
  • 10.3.1. Brazil Poultry Vaccines Market Outlook
    • 10.3.1.1. Market Size & Forecast
      • 10.3.1.1.1. By Value
    • 10.3.1.2. Market Share & Forecast
      • 10.3.1.2.1. By Application
      • 10.3.1.2.2. By Product
      • 10.3.1.2.3. By Disease Type
  • 10.3.2. Colombia Poultry Vaccines Market Outlook
    • 10.3.2.1. Market Size & Forecast
      • 10.3.2.1.1. By Value
    • 10.3.2.2. Market Share & Forecast
      • 10.3.2.2.1. By Application
      • 10.3.2.2.2. By Product
      • 10.3.2.2.3. By Disease Type
  • 10.3.3. Argentina Poultry Vaccines Market Outlook
    • 10.3.3.1. Market Size & Forecast
      • 10.3.3.1.1. By Value
    • 10.3.3.2. Market Share & Forecast
      • 10.3.3.2.1. By Application
      • 10.3.3.2.2. By Product
      • 10.3.3.2.3. By Disease Type

11. Market Dynamics

• 11.1. Drivers
• 11.2. Challenges

12. Market Trends & Developments

• 12.1. Merger & Acquisition (If Any)
• 12.2. Product Launches (If Any)
• 12.3. Recent Developments

13. Global Poultry Vaccines Market: SWOT Analysis

14. Porter's Five Forces Analysis

• 14.1. Competition in the Industry
• 14.2. Potential of New Entrants
• 14.3. Power of Suppliers
• 14.4. Power of Customers
• 14.5. Threat of Substitute Products

15. Competitive Landscape

• 15.1. Boehringer Ingelheim GmbH
  • 15.1.1. Business Overview
  • 15.1.2. Products & Services
  • 15.1.3. Recent Developments
  • 15.1.4. Key Personnel
  • 15.1.5. SWOT Analysis
• 15.2. Zoetis Inc
• 15.3. Elanco LLC
• 15.4. Intervet Inc
• 15.5. Hester Biosciences Ltd
• 15.6. Vaxxinova GmbH
• 15.7. Venky's India Ltd
• 15.8. Laboratorios Calier SA
• 15.9. KM Biologics Co Ltd
• 15.10. Phibro Animal Health Corporation

16. Strategic Recommendations

17. About Us & Disclaimer